Quality Investor

Core Molding Technologies, Inc.

Rank #338Value

CMT · NYSE · Basic Materials

Core Molding Technologies, Inc. (CMT) — Rank #338 by gross profitability (GP/assets 0.21) · ROE 7.0% · Piotroski F-Score 7 / 9.

As-of 2026-09-15 · CIK 0001026655 · all metrics point-in-time as of the filing date.

About

Core Molding Technologies, Inc., together with its subsidiaries, operates as a molder of thermoplastic and thermoset structural products in the United States, Mexico, Canada, and internationally.

Show more

The company offers a range of manufacturing processes, such as sheet molding compound compression molding, direct long fiber thermoplastic compression molding, vacuum resin transfer compression molding, structural foam and web injection molding, reaction injection molding, hand lay-up, and spray-up processes. It serves various markets, including medium and heavy-duty trucks, power sports, building products, industrial and utilities, and other commercial markets. The company was formerly known as Core Materials Corporation and changed its name to Core Molding Technologies, Inc. in August 2002. Core Molding Technologies, Inc.

was incorporated in 1996 and is headquartered in Columbus, Ohio.

Industry
Specialty Chemicals
Sector
Basic Materials
State
DE
Filer Category
Accelerated filerSmaller reporting company
Fiscal Year End
December 31
Website
coremt.com

Price History

CMT+72.7% · +11.6% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and dividend yield are the primary valuation lenses for mature businesses.

Market Cap

$199.18M

P/E (annual)

18.0

P/S (annual)

0.7

P/B

1.2

P/OCF (annual)

10.4

Shareholder Yield

-12.2%

Employees

1,239

Industry

Specialty Chemicals

Exchange

NYSE

Signal Flags

2 green1 yellow1 red
Deferred revenue growingRevenue and deferred revenue both growing — retention signal
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Valuation convergenceEPS declining, shares diluting, and revenue growth decelerating simultaneously

Quality Profile

Profitability

1/1 pass
GP / assets
0.21
Return on equity
7.0%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.41
Current ratio
2.00×
Net cash
$12.13M

Cash Flow

2/3 pass
Positive FCF
PASS
Cash-backed earnings
WARN
Accruals healthy
PASS
SBC / revenue
0.7%

Growth

1/2 pass
Revenue growth
1.6%
Piotroski F-Score
7 / 9
Share dilution
12.2%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

What Growth Is Priced In

Implied revenue growth (10Y)

30.7%

stretched

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 12.2% — per-share value needs a total required return of 42.9% once share-count change is priced in.

vs. own 6-year median revenue growth: 40.4%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

25.1%

r = 10% (base)

30.7%

r = 12%

35.5%

Net debt / market cap: -6.0%

Base FCF: $1.9M3Y mean FCF: -$5.1M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

18.6xExpensive
7.5xmed 10.4x27.5x

P / S

Price / revenue per share

0.3xFair
0.1xmed 0.3x0.7x

P / B

Price / book value per share

0.8xFair
0.2xmed 0.6x1.7x

P / GP

Price / gross profit per share

2.0xCheap
0.9xmed 2.1x4.0x

P / FCF

Price / free cash flow per share

84.4xExpensive
2.0xmed 8.1x84.4x

Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).

Profitability

Gross profitability (GP / assets)

0.21

Primary signal (Novy-Marx).

5th of 6 SIC 30 peers

Return on equity

7.0%

Gross margin

17.4%

6th of 6 SIC 30 peers

Revenue growth (YoY)

1.6%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2018201920202021
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

Revenue CAGR (5Y)

4.3%

Earnings CAGR (3Y)

-2.8%

FCF CAGR (3Y)

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.41

1st of 6 SIC 30 peers (best = lowest)

Current ratio

2.00×

4th of 6 SIC 30 peers

Quick ratio

0.98×

Net cash

$12.13M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$1.92M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

-0.83

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

WARN

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.7%

Stock-based comp intensity.

Piotroski F-Score

F-Score

7 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20162021
Hypergrowth
Startup
Op. Leverage